Lear at the College of Europe Career Day

Lear is excited to participate in the College of Europe Career Day in Bruges on March 12, 2025.

This event is a great opportunity for students to explore career paths in economic consulting, antitrust, and regulation. We will be present throughout the day to meet students, answer questions, and share insights into career opportunities at Lear.

Read more

Lear recognized by GCR as one of the Top 20 Competition Economics Firms

We are proud to announce that Global Competition Review has once again recognised Lear as one of the top 20 competition economics consultancies worldwide in the GCR💯 ranking! Read more

Lear Competition Festival 2025 – Registration is open!

This edition will be truly special as we celebrate 20 years of the Lear Conference! Get ready for new partners, cutting-edge topics, distinguished international speakers, and unique opportunities for the international antitrust community.

WHAT TO EXPECT FROM LCF25? Read more

Workshop – Relazioni Pericolose: Acquisizioni e innovazione nel settore farmaceutico – Slides e Video

Si è recentemente concluso il workshop “Relazioni Pericolose: Acquisizioni e Innovazione nel Settore Farmaceutico”, un evento che ha acceso il dibattito sulle killer acquisitions, ovvero quelle operazioni di acquisizione strategica che possono frenare l’innovazione nel settore farmaceutico.
L’incontro ha visto la partecipazione di esperti del settore, accademici e rappresentanti dell’industria, che hanno condiviso analisi approfondite, casi di studio e possibili scenari futuri. Durante il dibattito sono emersi spunti interessanti sulle dinamiche di mercato, sulle implicazioni regolatorie e sulle strategie per incentivare la competizione e l’innovazione.
Per chi non ha potuto partecipare o desidera approfondire, sono disponibili i materiali del workshop: Read more

Killing Me Softly: Pharma Acquisitions and Competitive Harm

🎉 We are pleased to share our latest Lear Competition Note, “Killing Me Softly: Pharma Acquisitions and Competitive Harm,” based on the report we prepared for the European Commission on the phenomenon of killer acquisitions in the pharmaceutical sector.

📊 In this analysis, Rossella Mossucca, Senior Consultant, and Clarissa Lotti, Consultant at Lear, delve into the key findings of the study, offering a comprehensive overview of:

• The occurrence of killer acquisitions in the pharmaceutical industry, where competitive innovation is stifled.
• Recommendations for enhancing competition authorities’ tools to address these challenges effectively.

The LCN is available here 
Read more

The ICA clears Iren of excessive pricing allegations

Lear – together with law firms Cleary Gottlieb and Grimaldi Alliance – has successfully assisted the Iren group in the context of an investigation by the Italian Competition Authority (“ICA”) into an alleged abuse of dominance in the district heating sector.
The investigation sought to ascertain whether price rises for the district heating service in the cities of Parma and Piacenza over the period 2021-2023 represented an instance of excessive pricing. The final decision issued by the ICA acknowledges that the prices charged by Iren were not excessive and no infringement occurred. Read more

Workshop – Relazioni Pericolose: Acquisizioni e innovazione nel settore farmaceutico

📢 Siamo entusiasti di annunciare il nostro prossimo evento: il workshop “Relazioni Pericolose: Acquisizioni e innovazione nel settore farmaceutico”, che si terrà a Milano il 29 gennaio 2025.

Il fenomeno delle killer acquisition – ovvero, le transazioni che hanno come obiettivo o effetto l’eliminazione di innovazioni potenzialmente concorrenti – è un tema che suscita crescente attenzione, soprattutto nel settore farmaceutico. Ma quanto è realmente diffuso questo fenomeno, e come possiamo identificarlo? Quali sono gli strumenti che le autorità della concorrenza possono utilizzare per esaminarle? Read more

Study on Killer Acquisitions in the Pharma Sector

We are thrilled to announce that our report on ‘killer acquisitions’ in the pharmaceutical sector has been published by the European Commission.

Read more

Lear takes part in the Business Networking Day organised by TSE

On November 29^th, Lear will be taking part in the Business Networking Day organized by the Toulouse School of Economics. A day that aims to foster connections between the labor market and the younger generation, offering several opportunities to expand networks. Read more

ICA’s decision against Bancomat’s project of direct fees for not-on-us withdrawals is final

At the end of October 2024, Bancomat S.p.A. (Bancomat) withdrew its appeal against an infringement decision adopted by the Italian Competition Authority (ICA). The decision concerned a project to switch from interchange fees to direct-fees for the remuneration of withdrawals at ATMs outside the cardholder’s bank’s network. According to the ICA this project violated Article 101 TFEU. During the proceedings and in the appeal, Lear assisted some of the Bancomat circuit’s banks that opposed the project. Read more